Nicholson Ryan

VP/CAO Nicholson Ryan sells 7,000 DLB shares at $84.07; retains 29,758 shares post-sale

Nicholson Ryan, VP, CAO and Corp. Controller, sold 7,000 shares of Dolby Laboratories at $84.07 on 2025-02-05, reducing his holdings by 19.0% to 29,758 shares and generating $588,480.20 in proceeds. The sale occurs with DLB trading near its 52-week highs (current price $84.43 is 3.3% below the $87.32 peak) and after a 12.4% gain over the prior 90 days, suggesting the insider exited into recent strength. His cross-ticker track record shows 1 prior sell with an average 30-day return of -2.0%, and his prior DLB sale on 2024-11-26 also posted a -2.0% 30-day return, indicating a modest historical pattern of selling ahead of near-term weakness. Against this, DLB's valuation at 30.81 P/E and annual revenue decline of -2.0% provide context for a potential reassessment of exposure, though the modest share reduction (from 36.8K to 29.8K) suggests measured rather than urgent portfolio action.

VP/Controller sells 10,500 DLB shares at $80.18; retains 24,364 shares post-transaction

Nicholson Ryan, VP, CAO and Corporate Controller, executed a sale of 10,500 shares at $80.18 on 2024-11-26, reducing his position by 30.1% from 34,864 shares to 24,364 shares. The sale occurred near the 52-week high range ($89.38), with the stock currently trading at $78.20, down 12.5% from its 52-week peak but up 7.1% over the past 30 days and 9.3% over 90 days. Given the executive's retention of a meaningful 24.4K-share position post-transaction, the sale represents partial portfolio adjustment rather than full exit. The company's fundamentals show stable net income of $38.4M against revenue of $288.8M, though annual revenue has contracted 2.0% year-over-year, and the stock's elevated P/E of 28.54 suggests investors have priced in growth expectations that may face near-term headwinds.